SAGA Diagnostics appoints Peter Collins as Chief Executive Officer

SAGA Diagnostics AB, (“SAGA”), a leading cancer liquid biopsy and genomic testing company, is pleased to announce the appointment of Peter Collins as Chief Executive Officer.

Mr. Collins is a highly experienced entrepreneur with over 30 years of experience in the pharma and diagnostics sector.

He joins SAGA after successful executive roles at major players in the liquid biopsy field such as Inivata as Chief Business Officer and at Guardant Health as VP Biopharma Business Development, and CBO of Yourgene. Peter was also VP, Head of Diagnostics at GSK for 5 years. Throughout his various executive positions, he has demonstrated a track record of building high performance teams and leading organizations’ commercial growth.